Study in Nature: MicroRNAs hold promise for treating diseases in blo...(iferation of VSMC had thickened blood ve...),Health

Date:7/5/2009

iferation of VSMC had thickened blood vessel walls. These findings suggest that miR-143 and miR-145 in partnership with myocardin maintain the normal balance between mature VSMC and their precursors. Thus, researchers believe the drop in miR-143 and miR-145 levels seen in disease settings contributes greatly to vessel wall thickening, but that theory will need to be confirmed by further studies.

In addition, Rochester investigators found that myocardin and SRF activate genes that may influence the rate at which the brain can remove amyloid beta, the toxic protein that builds up in blood vessels in the brains of patients with Alzheimer's disease. In a February 2009 article in the journal Nature Cell Biology, University of Rochester investigator, Berislav Zlokovic, M.D., Ph.D. found that when SRF and myocardin are active, amyloid beta accumulates in VSMC lining blood vessels. The discovery that miR-145 encourages the expression of myocardin could explain why myocardin may occur in higher levels in Alzheimer's disease, which is turning out to be a problem of "vascular plumbing."

"The finding that a microRNA controls levels of myocardin, the master regulator of VSMC identity and function, forms the starting point in efforts to design new classes of treatment for vascular diseases that represent leading causes of death," said Joseph M. Miano, Ph.D., associate professor within the Aab Cardiovascular Research Institute at the University of Rochester Medical Center, and a study author. He and Srivastava trained together under the direction of renowned muscle biologist Eric Olson at M.D. Anderson Cancer Center in the early 1990s. Miano was also a co-author of the paper on Alzheimer's with Zlokovic. "One of the most important of potential applications for this work would be to deliver miR-145 into vessel walls as a way to normalize levels of myocardin, which would counter vessel wall thickening."

Rochester provided GICD with samples o
'/>"/>

Contact: Greg Williams Greg_Williams@urmc.rochester.edu 585-273-1757 University of Rochester Medical Center Source:Eurekalert

1 GOOD

Page: 1 2 3 4
Related medicine news :

1. Rare sheep could be key to better diagnostic tests in developing world, says Stanford study
2. Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study
3. Overweight kids experience more loneliness, anxiety, MU study finds
4. Children with autism need to be taught in smaller groups, pilot study confirms
5. Predicting the return of prostate cancer: New Johns Hopkins study betters the odds of success
6. Study Casts Doubt on Low IQs Role in Early Death
7. Study shows PET can measure effectiveness of novel breast cancer treatment
8. New Study Shows Many Unplanned Quit Smoking Attempts are Successful
9. Study examines dietary influences of liver disease
10. Study examines liver transplantation after drug induced acute liver failure
11. Study Supports Wider Use of Statins